OTCReporter.com New Spotlight Stock-THRA
Watch list of Friday 2-26-2010
Our spotlight stock for tomorrow is… THRA
THRA issued important NEWS after the close today, make sure you read it…this could be the beginning of a huge run.
THRA has been on an upward trend all week, and has traded record high volume today!
Therma-Med inc., through our highly specialized Thermal Imaging and breakthrough alternative procedure services, is poised to become a healthcare industry leading company providing various medical support services as well as an adjunctive diagnostic procedure that effectively pursues and exposes the benefits of early detection and prevention of various medical conditions.
Check out Therma Med’s Website: http://www.therma-medinc.com/tmX/default.asp
Just last Friday THRA was trading big volume and up 83%, doesn’t take a lot to move this stock.
Just recently Therma-Med Inc. entered into the natural wellness health market providing premium quality vitamins, supplements and natural wellness products throughout North America.
Keep your eye on THRA, this could be a great entrance opportunity before momentum picks up!
OTCReporter.com and HotOTCChina.com are owned by Oceanic Consulting, LLC ("Oceanic") and Garden State Resources NJ, LLC ("Garden State"), both of which are New Jersey limited liability corporations (OTCReporter.com and Hot OTCChina.com and its owners, Oceanic and Garden State, and their affiliates, directors and officers and its immediate family members are referred to in our Disclaimer as "OTCR" or "we" or "us" or "our"). Oceanic and Garden State are referred to herein collectively as the "LLC Companies" when the context of the statements pertain to compensation matters, including our "Compensation Disclosure" section that seeks to comply with Section 17(b) of the 1933 act, as amended, which states that any person who disseminates publications or other communications (through interstate commerce) for consideration received or to be received, directly or indirectly, from
an issuer, underwriter, or dealer, must disclose the receipt and amount, whether past or prospective, of such consideration.
It is imperative that all readers of the above Compensation Disclosure Section click on the link below to carefully review our Disclaimer in its entirety, which contains important information about penny stocks, our operations, the limited nature of the information presented in our publications and various risks attendant to the companies that we profile.
Click to read our disclaimer
|This message was sent from OTCReporter to Subscriber. It was sent from: OTCReporter.com, P.O. Box 273, Rumson, NJ 07760. You can modify/update your subscription via the link below.
Email Marketing by